Pennsylvania Jury Awards $10M In 2nd Topamax Birth Defect Trial

Pennsylvania Jury Awards $10M In 2nd Topamax Birth Defect Trial

PHILADELPHIA - A Pennsylvania state court jury on Nov. 18 awarded more than $10 million to a family whose son was born with a cleft palate allegedly caused by his mother's use of the antiepileptic drug Topamax during pregnancy, according to one of the law firms representing the family (Brayden Gurley, et al. v. Ortho-McNeil-Janssen Pharmaceutical, Inc., No. 110502251, Pa. Comm. Pls., Philadelphia Co.).

Find full version on lexis Advance®
Access this news story on lexis.com®